share_log

サンバイオ:国内SB623慢性期外傷性脳損傷プログラム製造販売承認取得の状況について(続報)

SanBio: Status of obtaining manufacturing and sales approval for the domestic SB623 chronic traumatic brain injury program (follow-up report)

JPX ·  Mar 25 20:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more